Referências bibliográficas:


Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998;39: 237–8.

Bourlioux P, Pochart P. Nutritional and health properties of yogurt. World Rev Nutr Diet 1988;56:217–58.

Chandan RC, Shahani KM. Yogurt. In: Hui YH, ed. Dairy science and technology handbook. New York: VCH Publishers, Inc, 1993:1–57.

Metchnikoff E. Sur la flore du corps humain. (On the flora of the human body) Manch Lit Philos Soc 1901;45:1–38 (in French).

Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato NJ. Immune system stimulation by probiotics. J Dairy Sci 1995;78:1597–606.

Buttriss J. Nutritional properties of fermented milk products. Int J Dairy Tech 1997;50:21–7.

Reddy KP, ShahaniKM,Kulkarni SM. B-complex vitamins in cultured and acidified yogurt. J Dairy Sci 1976;59:191–5.

Shahani KM, Chandan RC. Nutritional and healthful aspects of cultured and culture-containing dairy foods. J Dairy Sci 1979;62:1685–94.

Kneifel W, Mayer HK. Vitamin profiles of kefirs made from milks of different species. Int J Food Sci Technol 1991;26:423–8.

Kneifel W, Kaufmann M, Fleischer A, Ulberth F. Screening of commercially available mesophilic dairy starter cultures: biochemical, sensory and morphological properties. J Dairy Sci 1992;75:3158–66.

Crittenden RG, Martinez NR, Playne MJ. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol 2003;80:217–22.

Wigertz K, Svensson UK, Ja¨gerstad M. Folate and folate binding protein content in dairy products. J Dairy Res 1996;64:239–54.

Rosado JL, Solomons NW, Allen LH. Lactose digestion from unmodified, low-fat and lactose-hydrolyzed yogurt in adult lactose maldigesters. Eur J Clin Nutr 1992;46:61–7.

Vesa TH, Marteau P, Korpela R. Lactose intolerance. J Am Coll Nutr 2000;19:165S–75S.

Kolars JC, Levitt MD, Aouji M, Savaiano DA. Yogurt—an autodigesting source of lactose. N Engl J Med 1984;310:1–3.

Goodenough ER, Kleyn DH. Influence of viable yogurt microflora on digestion of lactose by the rat. J Dairy Sci 1976;59:601–6.

Rasic JL, Kurmann JA. Yoghurt: scientific grounds, technology, manufacture and preparations. Vol 1 of Rasic JL, Kurmann JA, eds. Fermented fresh milk products and their cultures. Copenhagen: Technical Dairy Publishing House, 1978.

Loones A. Transformation of milk components during yogurt fermentation. In: Chandan RC, ed. Yogurt: nutritional and health properties. McLean, VA: National Yogurt Association, 1989:95–114.

Beshkova DM, Simova ED, Frengova GI, Simov ZI, Adilov EF. Production of amino acids by yogurt bacteria. Biotechnol Prog 1998;14: 963–5.

Hewitt D, Bancroft HJ. Nutritional value of yogurt. J Dairy Res 1985; 52:197–207.

Bissonnette DJ, Jeejeebhoy KN, eds. Meeting dietary nutrient requirements with cow’s milk and milk products. Rotterdam: Balkema, 1994.

Gaudichon C, Roos N, Mahé S, Sick H, Bouley C, Tomé D. Gastric emptying regulates the kinetics of nitrogen absorption from 15Nlabeled milk and 15N-labeled yogurt in miniature pigs. J Nutr 1994; 124:1970–7.

Gaudichon C, Mahé S, Roos N, et al. Exogenous and endogenous nitrogen flow rates and level of protein hydrolysis in the human jejunum after [15N] milk and [15N] yogurt ingestion. Br J Nutr 1995;74: 251–60.

Shantha NC, Ram LN, O’Leary J, Hicks CL, Decker EA. Conjugated linoleic acid concentrations in dairy products as affected by processing and storage. J Food Sci 1995;60:695–8.

Aneja RP, Murthi TN. Conjugated linoleic acid contents of Indian curd and ghee. Indian J Dairy Sci 1990;43:231–8.

Jiang J, Wolk A, Vessby B. Relation between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am J Clin Nutr 1999;70:21–7.

Park Y, McGuire MK, Behr R, McGuire MA, Evans MA, Schultz TD. High-fat dairy product consumption increases 9c; 11t–18:2 (rumenic acid) and total lipid concentrations of human milk. Lipids 1999;34: 543–9.

Boccignone M, Brigidi R, Sarra C. Studi effettuati sulla compo-sizione in trigliceridi ed acidi grassi liberi nello yogurt preparato dalatte vaccino, pecorinoe, caprino. (Studies on triglyceride and free fatty acid composition of yogurt prepared from cow, goat, and sheep milk.) Ann Fac Med Vet (Torino) 1984;28:223–33 (in Italian).

Whigham LD, Cook ME, Atkinson RL. Conjugated linoleic acid: implications for human health. Pharmacol Res 2000;42:503–10.

KempMQ,Jeffy BD, Romagnolo DF. Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J Nutr 2003;133:3670–7.

31. Block G, Abrams B. Vitamin and mineral status of women of childbearing potential. Ann N Y Acad Sci 1993;678:244–54.

Ervin RB, Kennedy-Stephenson J. Mineral intakes of elderly adult supplement and non-supplement users in the third National Health and Nutrition Examination Survey. J Nutr 2002;132:3422–7.

Allen LH. Calcium bioavailability and absorption: a review.AmJ Clin Nutr 1982;35:783–808.

KaupSM,ShahaniKM,AmerMA,Peo ER. (Bioavailability of calcium in yogurt.) Milchwissenschaft 1987;42:513–6 (in German).

Schaafsma GJ, Dekker PR, de Ward H. Nutritional aspects of yogurt. 2. Bioavailability of essential minerals and trace elements. Neth Milk Dairy J 1988;42:135–46.

Bronner F, Pansu D. Nutritional aspects of calcium absorption. J Nutr 1999;129:9–12.

Norman AW. Intestinal calcium absorption: a vitamin D-hormone–mediated adaptive response. Am J Clin Nutr 1990;51:290–300.

Pointillart A, Cayron B, Gueguen L. Calcium and phosphorus utilization and bone mineralization in yogurt-fed pigs. Sci Alim 1986;6:15–30.

Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994;35:483–9.

Alm L, Pettersson L. Survival rate of lactobacilli during digestion: an in vitro study Am J Clin Nutr 1980;33(suppl):S2543 (abstr).

Robins-Browne RM, Path FF, Levine MM. The fate of ingested lactobacilli in the proximal small intestine. Am J Clin Nutr 1981;34:514–9.

Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987;70:1–12.

Pedrosa MC, Golner BB, Goldin BR, Barakat S, Dallal GE, Russell RM. Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects. Am J Clin Nutr 1995;61:353–9.

Clark PA, Martin JH. Selection of bifidobacteria for use as dietary adjuvants in cultured dairy foods: III. Tolerance to stimulated bile concentrations of human small intestines. Cult Dairy Prod J 1994;29:18–21.

Duez H, Pelletier H, Cools S, et al. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces. J Appl Microbiol 2000;88:1019–27.

Guerin-Danan C, Chabanet C, Pedone C, et al. Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. Am J Clin Nutr 1998;67:111–7.

Bouhnik Y, Pochart P, Marteau P, Arlet G, Goderel I, Rambaud JC. Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology 1992;102:875–8.

Plant L, Conway P. Association of Lactobacillus spp. with Peyer's patches in mice. Clin Diagn Lab Immunol 2001;8:320–4.

Bernet MF, Brassart D, Neeser JR, Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Env Microbiol 1993;59:4121–8.

Lerebours E, N'Djitoyap Ndam C, Lavoine A, Hellot MF, Antoine JM, Colin R. Yogurt and fermented-then-pasteurized milk: effects of short-term and long-term ingestion on lactose absorption and mucosal lactase activity in lactase-deficient subjects. Am J Clin Nutr 1989;49:823–7.

Kankaanpää P, Salminen SJ, Isolauri E, Lee YK. The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett 2001;194:149–53.

Kankaanpää P, Yang B, Kallio H, Isolauri E, Salminen S. Effects of polyunsaturated fatty acids in growth medium on lipid composition and on physicochemical surface properties of Lactobacilli. Appl Env Microbiol 2004;70:129–36.

Aguirre M, Collins MD. Lactic acid bacteria and human clinical infection. J Appl Bacteriol 1993;75:95–107.

Brandtzaeg P, Baekkevold ES, Farstad IN, et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999;20:141–51.

Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000;288:2222–6.

Puri P, Rattan A, Bijlani RL, Mahapatra SC, Nath I. Splenic and intestinal lymphocyte proliferation response in mice fed milk or yogurt and challenged with Salmonella typhimurium. Int J Food Sci Nutr 1996;47:391–8.

Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intakes. FEMS Immunol Med Microbiol 1994;10:55–64.

Perdigon G, de Macias ME, Alvarez S, Oliver G, de Ruiz Holgado AA. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 1988;63:17–23.

Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348–57.

Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor-alpha, interleukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996;64:5403–5.

Solis-Pereyra B, Aattouri N, Lemonnier D. Role of food in the stimulation of cytokine production. Am J Clin Nutr 1997;66(suppl):521S–5S.

Halpern GM, Vruwink KG, van de Water J, Keen CL, Gershwin ME. Influence of long-term yogurt consumption in young adults. Int J Immunother 1991;7:205–10.

Borruel N, Carol M, Casellas F, et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002;51:659–64.

De Simone C, Bianchi Salvadori B, Negri M, Ferrazzi M, Baldinelli L, Vesely R. The adjuvant effect of yogurt on production of gamma-interferon by Con A stimulated human peripheral blood lymphocytes. Nutr Rep Int 1986;33:419–33.

Beharka AA, Paiva S, Leka LS, Ribaya-Mercado JD, Russell RM, Nibkin Meydani S. Effect of age on the gastrointestinal-associated mucosal immune response of humans. J Gerontol A Biol Sci Med Sci 2001;56:B218–23.

Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–29.

Ajuebor MN, Swain MG. Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 2002;105:137–43.

Wallace TD, Bradley S, Buckley ND, Green-Johnson JM. Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. Food Prot 2003;66:466–72.

Strandhagen E, Lia A, Lindstrand S, et al. Fermented milk (ropy milk) replacing regular milk reduces glycemic responce and gastric emptying in healthy subjects. Scand J Nutr 1994;38:117–21.

Nakamura T, Nishida S, Mizutani M, Iino H. Effects of yogurt supplemented with brewer's yeast cell wall on constipation and intestinal microflora in rats. J Nutr Sci Vitaminol (Tokyo) 2001;47:367–72.

Meance S, Cayuela C, Turchet P, Raimondi A, Lucas C, Antoine JM. A fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened oro-fecal gut transit time in elderly. Microb Ecol Health Dis 2001;13:217–22.

Marteau P, Cuillerier E, Meance S, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002;16:587–93.

Rorick MH, Scrimshaw NS. Comparative tolerance of elderly from differing ethnic backgrounds to lactose-containing and lactose-free dairy drinks: a double-blind study. J Gerontol 1979;34:191–6.

Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol 1994;202:7–20.

Savaiano DA, AbouElAnouar A, Smith DE, Levitt MD. Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals. Am J Clin Nutr 1984;40:1219–23.

Pochart P, Dewit O, Desjeux JF, Bourlioux P. Viable starter culture, ß-galactosidase activity, and lactose in duodenum after yogurt ingestion in lactase-deficient humans. Am J Clin Nutr 1989;49:828–31.

Hickey MW, Hillier AJ, Jago GR. Transport and metabolism of lactose, glucose, and galactose in homofermentative lactobacilli. Appl Environ Microbiol 1986;51:825–31.

Foucaud C, Poolman B. Lactose transport system of Streptococcus thermophilus. J Biol Chem 1992;267:22087–94.

Thoreux K, Balas D, Bouley C, Senegas-Balas F. Diet supplemented with yoghurt or milk fermented by Lactobacillus casei DN-114 001 stimulates growth and brush-border enzyme activities in mouse small intestine. Digestion 1998;59:349–59.

Martini MC, Bollweg GL, Levitt MD, Savaiano DA. Lactose digestion by yogurt ß-galactosidase: influence of pH and microbial cell integrity. Am J Clin Nutr 1987;45:432–6.

Glass RI, Lew JF, Gangarosa RE, LeBaron CW, Ho MS. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 1991;118:S27–33.

Van Neil CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002;109:678–84.

Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in a hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344:1046–9.

Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;2:1519(letter).

Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995;21:224–6.

Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 1997;86:460–5.

Clements ML, Levine MM, Ristaino PA, Daya VE, Huges TP. Exogenous lactobacilli fed to man—their fate and ability to prevent diarrheal disease. Prog Food Nutr Sci 1983;7:29–37.

Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992;15:573–81.

Van der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol 1989;43:69–87.

D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002;324:1–6.

Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin associated diarrhoea with Lactobacillus preparation. Am J Hosp Pharm 1979;36:754–7.

Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 1990;24:382–4.

Orrhage K, Brismar B, Nord CE. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on intestinal microbiota during administration of clindamycin. Microb Ecol Health Dis 1994;7:17–25.

Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhoea in children. J Pediatr 1999;135:356–68.

National Cancer Institute. SEER Cancer Incidence Public-Use Database, 1973-1996, August 1998 Submission. Bethesda, MD: US Department of Health and Human Services, Public Health Service, 1999.

Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 1992;3:457–73.

Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res 1993;53:3914–8.

Ayebo AD, Shahani KM, Dam R. Antitumor component(s) of yogurt: fractionation. J Dairy Sci 1981;64:2318–23.

Shackelford LA, Rao DR, Chawan CB, Pulusani SR. Effect of feeding fermented milk on the incidence of chemically induced colon tumors in rats. Nutr Cancer 1983;5:159–64.

100. Wollowski I, Ji S, Bakalinsky AT, Neudecker C, Pool-Zobel BL. Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr 1999;129:77–82.

Bolognani F, Rumney CJ, Pool-Zobel BL, Rowland IR. Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur J Nutr 2001;40:293–300.

Ganjam LS, Thornton WH, Marshall RT, MacDonald RS. Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells. J Dairy Sci 1997;80:2325–9.

Kim DH, Jin YH. Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arch Pharm Res 2001;24:564–7.

Reddy BS, Engle A, Simi B, Goldman M. Effect of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. Gastroenterology 1992;102:1475–82.

Goldin BR, Gorbach SL. Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J Natl Cancer Inst 1984;73:689–95.

Goldin BR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984;39:756–61.

Rafter JJ. The role of lactic acid bacteria in colon cancer prevention. Scand J Gastroenterol 1995;30:497–502.

Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S–11S.

Kwon HJ, Cote TR, Cuffe MS, Kramer JM, Braun MM. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 2003;138:807–11.

Fabia R, Ar'Rajab A, Johansson ML, et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993;54:248–55.

McCormick DA, Horton LW, Mee AS. Mucin depletion in inflammatory bowel disease. J Clin Pathol 1990;43:143–6.

van Wijngaarden P, Meijssen MA. Tuberculous pleurisy: an unusual complication during treatment of Crohn disease with azathioprine. Scand J Gastroenterol 2001;37:1004–7.

Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999;116:1107–14.

Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352–5.

Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996;40:137–45.

Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;32:141–4.

Marshall BJ. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273–5.

Labigne A, de Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis 1996;5:191–202.

Duggan A. Helicobacter pylori: when is treatment now indicated? Int Med J 2002;32:465–9.

Aiba Y, Suzuki N, Kabir AMA, Takagi A, Koga Y. Lactic acid-mediated supression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnobiotic murine model. Am J Gastroenterol 1998;93:2097–101.

Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995;79:475–9.

Coconnier M, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Env Microbiol 1998;64:4573–80.

Kim TS, Hur JW, Yu MA, et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 2003;66:3–12.

Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001;63:1–7.

Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999;60:203–9.

Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humns. J Antimicrob Chemother 2001;47:709–10.

Cats A, Kuipers EJ, Bosschaert MAR, Pot RGJ, Vandenbroucke-Grauls CMJE, Kusters JG. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 2003;17:429–35.

Kalliomäki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003;3:15–20.

Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003;36:223–7.

Isolauri E. Studies on Lactobacillus GG in food hypersensitivity disorders. Nutr Today 1996;31:28S–31S.

Gurr MI. The nutritional role of cultured dairy products. Can Inst Food Sci Technol 1984;17:57–64.

Rytkönen J, Karttunen TJ, Karttunen R, et al. Effect of heat denaturation on beta-lactoglobulin-induced gastrointestinal sensitization in rats: denatured ßLG induces a more intensive local immunologic response than native ßLG. Pediatr Allergy Immunol 2002;13:269–77.

Bischoff SC, Mayer JH, Manns MP. Allergy and the gut. Int Arch Allergy Immunol 2000;121:270–83.

Miettinen M, Matikainen S, Vuopio-Varkila J, et al. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 1998;66:6058–62.

Shida K, Makino K, Morishita A, et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998;115:278–87.

Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infection. Bull Inst Pasteur 1994;92:45–67.

MacGregor G, Smith AJ, Thakker B, Kinsella J. Yoghurt biotherapy: contraindicated in immunosuppressed patients? Postgrad Med J 2002;78:366–7.

Schlegel L, Lemerle S, Geslin P. Lactobacillus species as opportunistic pathogens in immune-compromised patients. Eur J Clin Microbiol Infect Dis 1998;17:887–8.

Bayer AS, Chow AW, Betts D, Guze LB. Lactobacillemia—report of nine cases. Important clinical and therapeutic considerations. Am J Med 1978;64:808–13.

Horwitch CA, Furseth HA, Larson AM, Jones TL, Olliffe JF, Spach DH. Lactobacillemia in three patients with AIDS. Clin Infect Dis 1995;21:1460–2.

Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997;25:1048–55.

Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JMT. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999;5:290–2.

Presterl E, Kneifel W, Mayer HK, Zehetgruber M, Makristathis A, Graninger W. Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis 2001;33:710–4.

Avlami A, Kordossis T, Vrizidis N, Sipsas NV. Lactobacillus rhamnosus endocarditis complicating colonoscopy. J Infect 2001;42:283–5.